Skip to main content

Kidney Transplant Patients EFC18554 FREXERA

Status: Coming Soon

Study details

View study details on clinicaltrials.gov.

Locations

  • San Francisco

Clinical trial FAQs

Information for patients and study volunteers, including frequently asked questions.

A Seamless Phase 2/3 Randomized, Open-label Study to Investigate Efficacy and Safety of Frexalimab Versus Tacrolimus in Adult Kidney Transplant Recipients

V Ram Peddi, M.D., FASN, FAST
V Ram Peddi, M.D., FASN, FAST
Principal investigator
View profile

Sub-Investigator

Parul S Patel. M.D.

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?